Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stent patents for CardioVascular Dynamics:

This article was originally published in Clinica

Executive Summary

Two new US patents have given CardioVascular Dynamics a strong range of claims for balloon-free stent technology. The patents, for its Matrix self-expanding stent technology, bring the total the company holds in the US to eight. Self-expanding stents could cause less damage to the vessel wall when inserted. The company will begin European trials of the stent in peripheral vessels in the second quarter of 1998 and in coronary arteries before the end of the year.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts